"Our commitment to delivering unmatched procedural sophistication drove sector-leading growth once again in 2022," said Pat Miles, chairman and CEO. "As we look to the year ahead, we are as bullish as ever! We intend to continue to not just penetrate, but expand the market for lateral spine surgery and advance the influence of EOS. Our strategy to earn surgeon confidence through clinical distinction has and will continue to set ATEC apart, enabling us to successfully execute our strategic and financial commitments."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ATEC:
